Banning flavored tobacco sales to protect youth health

Aug.08.2022
Banning flavored tobacco sales to protect youth health
Bangor City Council reinstates ban on flavored tobacco sales to prevent youth vaping and smoking.

In October of last year, the council of the city of Bangor voted to ban the sale of flavored tobacco in order to prevent young people from vaping and smoking.


The Los Angeles County Department of Public Health's poster emphasizes the dangers of flavored tobacco. Source: Damian Dovarganes/AP.


After a vote of 7 to 1, a city lawyer has notified city council members that an ordinance set to take effect on June 1 must be repealed because the city failed to adequately notify tobacco retailers that it was considering the ban. Bangor City attorney David Szewczyk told council members in April that the city was required to directly notify local tobacco retailers at least 30 days before considering the ordinance because it was more restrictive than state law. Due to the lack of notification, the ban has been repealed before taking effect.


Now, almost 10 months later, the ban on the sale of flavored tobacco is once again being presented to the city council.


Unless there have been some changes since October - which we do not believe have taken place - the council should reissue the ban.


The rate of tobacco use among teenagers is on the rise, especially with regards to e-cigarettes. Based on a statewide health survey, in 2019 over a quarter of high school students in Maine reported using e-cigarettes, nearly double the rate from two years prior. Additionally, 16% of middle school students reported trying e-cigarettes in 2019, which is a rise from the 10% reported in 2017.


Across the country, 85% of young people who use e-cigarettes opt for flavored varieties. These products come in hundreds of different flavors, with many sounding like candy or soda, making them particularly appealing to young people.


According to data from the US Food and Drug Administration, three-quarters of current tobacco users report that their first tobacco product was flavored. The agency also reports that almost all smoking starts at the age of 18.


The FDA has proposed a rule to ban additional flavored tobacco products nationwide.


It is essential to keep tobacco products away from young people. Currently, it is illegal to sell tobacco products to anyone under 21 in Maine. However, the results of a youth health survey and state compliance report show that there are still many gaps in this law.


Banning the sale of flavored tobacco in one of the largest cities in the state will help fill these gaps and save lives and taxpayer money.


Bangor became the first community in Maine to vote last fall to ban the sale of flavored tobacco products. Portland passed its own anti-flavored tobacco sales ordinance in February, and Brunswick passed one in April. Both became effective on June 1st. Other communities are considering their own bans.


A statewide bill (LD 1550) that would ban flavored tobacco products in Maine has been put on hold as the legislative body has not taken final action.


Tobacco retailers and store owners are correct in stating that a statewide ban would make more sense than a community-by-community approach. However, in the absence of legislative action, bans in cities such as Bangor, Portland, and Brunswick may spur statewide action.


After presenting the evidence last year, the Bangor city council member strongly supported the ban. The evidence remains unchanged and their vote should not be altered.


Statement:


This article is compiled from third-party information for the purpose of industry communication and learning.


The article does not represent the views of 2FIRSTS and 2FIRSTS cannot confirm the accuracy or truthfulness of the article's content. The translation of this article is solely for use in industry exchange and research.


Due to limited translation abilities, the translated article may not fully express the same message as the original. Please refer to the original article for accuracy.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.


The copyright of the compiled information belongs to the original media and the author. If there is any infringement, please contact us for removal.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland Raises Nicotine Product Taxes Again as Cigarettes Gain €1 and Vape Duty Is Set to Jump 40%
Ireland has increased tobacco excise under Budget 2027 and announced a further rise in its E-liquid Products Tax. From Oct. 7, the tax burden on a pack of 20 cigarettes in the most popular price category increased by €1, with pro-rata increases on other tobacco products. The government plans to raise EPT from €0.50 to €0.70 per millilitre from Jan. 1, 2027, a 40% increase applying to both nicotine-containing and nicotine-free e-liquids. The tobacco duty increase is expected to raise about €63.1 million in a full year.
Regulations
Oct.09
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
Bret Koplow Takes Permanent Charge of FDA Tobacco Center After Pushing Faster PMTA Reviews, as HHS Emphasizes Innovation and Access to Lower-Risk Alternatives
The U.S. Department of Health and Human Services has named Bret Koplow permanent director of the FDA’s Center for Tobacco Products, ending his period as acting chief. Koplow has spent years working on tobacco regulation, law and policy inside the FDA and, while serving as acting director, pushed for faster PMTA reviews and nicotine pouch review pilots. HHS also said CTP will prioritize innovation and access to less harmful alternatives for adult smokers while continuing efforts to protect youth.
Sep.09
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia Extends Illicit Tobacco Crackdown From Tougher Penalties to Customs and Logistics Supply Chains
Australia's federal government introduced a new illicit tobacco enforcement bill on September 10 that would strengthen evidentiary presumptions, representative sampling, seizure and forfeiture procedures, proceeds-of-crime powers and obligations for customs and logistics operators. The proposal follows the Combatting Illicit Tobacco Act 2026, which took effect in August and increased penalties while expanding investigative and asset-recovery tools. Together, the reforms extend Australia's crackdown from tougher criminal sanctions into import, logistics and evidentiary enforcement.
Sep.14
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
Philippines Mandates Safety Certification for Nicotine Pouches, Gives Industry 12 Months to Comply
The Philippines Department of Trade and Industry has placed nicotine pouches under mandatory product certification through Department Administrative Order No. 26-07, Series of 2026. Nicotine pouches must obtain a Philippine Standard, or PS, license before they can be manufactured, imported, packed, distributed or sold in the country. The regime requires testing for nicotine content, pH and water activity, while packaging must disclose nicotine strength, ingredients, allergens, batch information, the PS certification mark and prescribed health warnings. Existing market participants have a 12-month transition period to comply.
Regulations
Oct.12
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Product | JT to Launch MEVIUS Tropical Option in Japan, Expanding Ploom Tobacco Stick Lineup to 32
Japan Tobacco (JT) will launch MEVIUS Tropical Option, a new tobacco stick for Ploom, nationwide in Japan from October 6, 2026. The capsule-format product combines mango-oriented sweetness with menthol cooling, adding a tropical flavor to the MEVIUS Ploom tobacco-stick lineup for the first time. Each pack contains 20 sticks and will launch at JPY 590. The product is compatible with all Ploom devices, and its addition will expand the Ploom tobacco-stick portfolio to 32 variants.
Sep.08